Antonio Finelli

19.7k total citations
477 papers, 11.2k citations indexed

About

Antonio Finelli is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Antonio Finelli has authored 477 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 348 papers in Pulmonary and Respiratory Medicine, 138 papers in Surgery and 118 papers in Molecular Biology. Recurrent topics in Antonio Finelli's work include Prostate Cancer Diagnosis and Treatment (162 papers), Renal cell carcinoma treatment (155 papers) and Prostate Cancer Treatment and Research (148 papers). Antonio Finelli is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (162 papers), Renal cell carcinoma treatment (155 papers) and Prostate Cancer Treatment and Research (148 papers). Antonio Finelli collaborates with scholars based in Canada, United States and United Kingdom. Antonio Finelli's co-authors include Neil Fleshner, Michael A.S. Jewett, Andrew Evans, Alexandre R. Zlotta, Inderbir S. Gill, Girish S. Kulkarni, Shabbir M.H. Alibhai, Jaimin R. Bhatt, Mihir Desai and Jihad Kaouk and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Antonio Finelli

451 papers receiving 11.0k citations

Peers

Countries citing papers authored by Antonio Finelli

Since Specialization

Citations

This map shows the geographic impact of Antonio Finelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Finelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Finelli more than expected).

Fields of papers citing papers by Antonio Finelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Finelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Finelli. The network helps show where Antonio Finelli may publish in the future.

Co-authorship network of co-authors of Antonio Finelli

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Finelli. A scholar is included among the top collaborators of Antonio Finelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Finelli. Antonio Finelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients 2025 ·Cancers ·(unknown), (unknown), Sunita Ghosh, (unknown), Lori Wood, C. Kollmannsberger, Naveen S. Basappa, Jeffrey Graham, Nazanin Fallah‐Rad, Daniel Yick Chin Heng, Denis Soulières, Aly‐Khan A. Lalani, Rodney H. Breau, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Georg A. Bjarnason, Frédéric Pouliot, Christina Canil	2
2	Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma 2025 ·The Oncologist ·(unknown), Zineb Hamilou, Sunita Ghosh, Daniel Yick Chin Heng, Lori Wood, Naveen S. Basappa, Christian Kollmannsberger, Jeffrey Graham, Bimal Bhindi, Antonio Finelli, Georg A. Bjarnason, Dominick Bossé, Frédéric Pouliot, Vincent Castonguay, Rodney H. Breau, Ramy Saleh, Eric Winquist, Aly‐Khan A. Lalani, Denis Soulières	1
3	MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial 2024 ·Radiology ·Sangeet Ghai, Antonio Finelli, (unknown), Katherine Lajkosz, Stuart A. McCluskey, Rosanna Chan, Mark R. Gertner, Theodorus van der Kwast, Peter Incze, Alexandre R. Zlotta, Walter Kucharczyk, Nathan Perlis	10
4	Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance 2023 ·Urologic Oncology Seminars and Original Investigations ·Guan Hee Tan, Dominik Deniffel, Antonio Finelli, Marian S. Wettstein, Ardalan E. Ahmad, Alexandre R. Zlotta, Neil Fleshner, Robert J. Hamilton, Girish S. Kulkarni, Gregory J. Nason, Khaled Ajib, Jaime O. Herrera‐Cáceres, Thenappan Chandrasekar, Nathan Perlis	0
5	A Matched Analysis of Active Surveillance Versus Nephrectomy for T1a Small Renal Masses 2023 ·European Urology Oncology ·Douglas C. Cheung, Lisa Martin, Maria Komisarenko, Kristen McAlpine, Shabbir M.H. Alibhai, Antonio Finelli	7
6	Quantitative and qualitative impact of physician assistants in a Canadian urology setting 2023 ·Canadian Urological Association Journal ·(unknown), Katherine Lajkosz, Miran Kenk, Antonio Finelli, Neil Fleshner	2
7	Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System 2023 ·JCO Global Oncology ·(unknown), Sunita Ghosh, Antonio Finelli, Lori Wood, Christian Kollmannsberger, Naveen S. Basappa, Jeffrey Graham, Daniel Y.C. Heng, Georg A. Bjarnason, Denis Soulières, Dominick Bossé, Vincent Castonguay, Ramy Saleh, Simon Tanguay, Bimal Bhindi, Rodney H. Breau, Frédéric Pouliot, Aly‐Khan A. Lalani	1
8	Surgeon-level versus hospital-level quality variance in kidney cancer surgery 2023 ·Urologic Oncology Seminars and Original Investigations ·Kristen McAlpine, Keith A. Lawson, Olli Saarela, Bo Chen, Brigid Wilson, Robert Abouassaly, Madhur Nayan, Antonio Finelli	2
9	Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men 2022 ·Radiology ·Sangeet Ghai, Nathan Perlis, (unknown), (unknown), (unknown), Katherine Lajkosz, Peter Incze, Alexandre R. Zlotta, Umesh Jain, (unknown), Antonio Finelli, Theodorus van der Kwast, Masoom A. Haider	22
10	Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative 2021 ·Urologic Oncology Seminars and Original Investigations ·Benjamin Shiff, Rodney H. Breau, Ranjeeta Mallick, Frédéric Pouliot, Alan So, Simon Tanguay, Anil Kapoor, Jean‐Baptiste Lattouf, Luke T. Lavallée, Adrian Fairey, Antonio Finelli, Bimal Bhindi, Jun Kawakami, Ricardo Rendon, (unknown)	13
11	Management of complex renal cysts in Canada: results of a survey study 2020 ·BMC Urology ·Félix Couture, Antonio Finelli, Amélie Têtu, Bimal Bhindi, Rodney H. Breau, Anil Kapoor, Wassim Kassouf, Luke T. Lavallée, Simon Tanguay, Philippe D. Violette, Patrick O. Richard	4
12	Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada 2020 ·European Urology Open Science ·Lei Dong, Wei Xu, Dixon Woon, Cynthia Kuk, (unknown), (unknown), (unknown), Oumin Shi, Baijun Dong, Michael Nesbitt, Stefan Carlsson, Girish S. Kulkarni, Ruth Hamilton, Antonio Finelli, Neil Fleshner, Ants Toi, Theodorus van der Kwast, Wei Xue, A. Zlotta	2
13	Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass 2020 ·Urologic Oncology Seminars and Original Investigations ·Hanan Goldberg, (unknown), Jaime O. Herrera‐Cáceres, Alejandro Berlín, Thenappan Chandrasekar, Zachary Klaassen, Christopher J.D. Wallis, Ardalan E. Ahmad, Ricardo Leão, Anika Petrella, John R. Kachura, Neil Fleshner, Andrew Matthew, Antonio Finelli, Michael A.S. Jewett, Robert J. Hamilton	21
14	Searching for prognostic biomarkers for small renal masses in the urinary proteome 2019 ·International Journal of Cancer ·Ashley Di Meo, Ihor Batruch, Marshall Brown, (unknown), Antonio Finelli, Michael A.S. Jewett, Eleftherios P. Diamandis, George M. Yousef	29
15	Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis 2019 ·Urologic Oncology Seminars and Original Investigations ·Madhur Nayan, (unknown), Anil Kapoor, Antonio Finelli, Alan So, Ricardo Rendon, Rodney H. Breau, Luke T. Lavallée, Simon Tanguay, Daniel Y.C. Heng, Jun Kawakami, Naveen S. Basappa, Georg A. Bjarnason, Frédéric Pouliot, Robert J. Hamilton	2
16	Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2 2019 ·Urologic Oncology Seminars and Original Investigations ·Emily C L Wong, (unknown), Rodney H. Breau, Frédéric Pouliot, Antonio Finelli, Luke T. Lavallée, Alan So, Simon Tanguay, Adrian Fairey, Ricardo Rendon, Patrick O. Richard, Jean‐Baptiste Lattouf, Jun Kawakami, Ranjeeta Mallick, Anil Kapoor	23
17	miR-10b is a prognostic marker in clear cell renal cell carcinoma 2017 ·Journal of Clinical Pathology ·Heba Khella, (unknown), (unknown), Andreas Scorilas, Roy Nofech‐Mozes, (unknown), Sergey N. Krylov, (unknown), Adriana Krizova, Antonio Finelli, Yufeng Cheng, George M. Yousef	31
18	A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy 2016 ·Clinical Cancer Research ·Rashid K. Sayyid, Andrew Evans, Karen Hersey, (unknown), Antonio Hurtado‐Coll, Girish S. Kulkarni, Antonio Finelli, Alexandre R. Zlotta, Robert J. Hamilton, Martin Gleave, Neil Fleshner	34
19	Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue 2013 ·Cancer Prevention Research ·Angeline A. Giangreco, (unknown), Dennis Wagner, Antonio Finelli, Neil Fleshner, Theodorus van der Kwast, Reinhold Vieth, Larisa Nonn	75
20	Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: Observations on DNA, RNA, protein extractions and VHL mutation detection 2011 ·Pathology - Research and Practice ·Ghada Kurban, Brenda L. Gallie, Michael Leveridge, Andrew Evans, Diane Rushlow, (unknown), Rashi Gupta, Antonio Finelli, Michael A.S. Jewett	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact